According to a recent LinkedIn post from Carta Healthcare, administrative work is cited as accounting for about 25% of healthcare costs, with artificial intelligence increasingly used to ease this burden. The post notes that while billing, prior authorizations, and denial management often receive attention, clinical data abstraction is a lesser-known but high-cost, labor-intensive function underpinning quality reporting and reimbursement.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The company’s LinkedIn post highlights that clinical abstraction in many health systems remains largely manual, time-consuming, and difficult to scale or staff consistently. Citing Gartner guidance, the post frames clinical abstraction as a high-volume, well-defined process where remaining manual carries tangible costs, implying it is a strong candidate for automation.
The post suggests that purpose-built AI combined with expert human oversight can accelerate abstraction workflows and improve consistency, potentially increasing confidence in the data used for quality and reimbursement decisions. For investors, this emphasis points to a growing market opportunity in AI-driven clinical data solutions that address administrative inefficiencies and support more reliable financial outcomes for provider organizations.
If Carta Healthcare can capture demand in this niche, it may strengthen its positioning within healthcare IT by targeting a critical but under-automated cost center. Such capabilities could enhance the company’s value proposition to hospitals and health systems seeking to reduce administrative expenses without adding risk, potentially supporting longer-term revenue growth and deeper enterprise adoption.